These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19509)

  • 1. Clinical pharmacokinetics of lorazepam. IV. Long-term oral administration.
    Greenblatt DJ; Knowles JA; Comer WH; Shader RI; Harmatz JS; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):495-500. PubMed ID: 19509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA; Greenblatt DJ; Shader RI
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
    Greenblatt DJ; Comer WH; Elliott HW; Shader RI; Knowles JA; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):490-4. PubMed ID: 19508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations and clinical effects of lorazepam after oral administration.
    Bradshaw EG; Ali AA; Mulley BA; Rye RM
    Br J Anaesth; 1981 May; 53(5):517-22. PubMed ID: 6112997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.
    Greenblatt DJ; Joyce TH; Comer WH; Knowles JA; Shader RI; Kyriakopoulos AA; MacLaughlin DS; Ruelius HW
    Clin Pharmacol Ther; 1977 Feb; 21(2):222-30. PubMed ID: 13960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lorazepam levels. A study following single dose administration of 2 and 4 mg by different routes.
    Dundee JW; Lilburn JK; Toner W; Howard PJ
    Anaesthesia; 1978 Jan; 33(1):15-9. PubMed ID: 24357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of lorazepam in monkey plasma.
    Walmsley LM; Chasseaud LF
    J Chromatogr; 1981 Nov; 226(1):155-63. PubMed ID: 6119319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of lorazepam.
    Diamond MJ
    Br J Anaesth; 1978 Jul; 50(7):730. PubMed ID: 28132
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers.
    Hildebrand M; Hellstern A; Hümpel M; Hellenbrecht D; Saller R
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):19-26. PubMed ID: 1974495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam: glucuronide formation in the cat.
    Schillings RT; Sisenwine SF; Schwartz MH; Ruelius HW
    Drug Metab Dispos; 1975; 3(2):85-8. PubMed ID: 236163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose lorazepam kinetics: shuttling of lorazepam glucuronide between the circulation and the gut during day- and night-time dosing intervals in response to feeding.
    Chaudhary A; Lane RA; Woo D; Herman RJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1034-8. PubMed ID: 8263762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam.
    Greenblatt DJ; Franke K; Shader RI
    J Chromatogr; 1978 Sep; 146(2):311-20. PubMed ID: 29907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses.
    Caillé G; Spénard J; Lacasse Y; Brennan J
    Biopharm Drug Dispos; 1983; 4(1):31-42. PubMed ID: 6132630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk.
    Hümpel M; Stoppelli I; Milia S; Rainer E
    Eur J Clin Pharmacol; 1982; 21(5):421-5. PubMed ID: 6122580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration.
    Wermeling DP; Miller JL; Archer SM; Manaligod JM; Rudy AC
    J Clin Pharmacol; 2001 Nov; 41(11):1225-31. PubMed ID: 11697755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action.
    Greenblatt DJ; Divoll M
    Adv Neurol; 1983; 34():487-91. PubMed ID: 6131586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal impairment and hemodialysis on lorazepam kinetics.
    Morrison G; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1984 May; 35(5):646-52. PubMed ID: 6713774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.